Skip to main content
. 2021 Nov 11;80(2):397–406. doi: 10.1111/his.14562

Figure 1.

Figure 1

Two head and neck squamous cell carcinoma samples (A, D, haematoxylin and eosin) analysed with the 22C3 PharmDx assay (B, E) and the SP263 assay (C, F). Programmed death‐ligand 1 expression as determined with the 22C3 and SP263 antibodies shows similar combined positive score (CPS) values in the two cases (AC, CPS ≥ 20; DF, CPS < 20).